1 – 10 of 106
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
- Etanercept versus monoclonal antibodies in axial spondyloarthritis: game over?
- A20 controls intestinal homeostasis through cell-specific activities
- Cancer-associated adipose tissue promotes breast cancer progression by paracrine Oncostatin M and Jak/STAT3 signaling
- Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
- Inequities in access to biologic and synthetic DMARDs across 46 European countries
- Inflammasomes in respiratory disease: from bench to bedside
- Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells
- Relevance of the gut/joint axis for the management of spondyloarthritis in daily clinical practice
- Regulation and dysregulation of tumor necrosis factor receptor-1
- Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force